↓ Skip to main content

Dove Medical Press

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives

Overview of attention for article published in Therapeutics and Clinical Risk Management, September 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

blogs
1 blog
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
24 Mendeley
Title
Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
Published in
Therapeutics and Clinical Risk Management, September 2021
DOI 10.2147/tcrm.s269336
Pubmed ID
Authors

Miles B Markus

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 5 21%
Researcher 4 17%
Student > Master 2 8%
Professor 1 4%
Other 1 4%
Other 2 8%
Unknown 9 38%
Readers by discipline Count As %
Design 4 17%
Biochemistry, Genetics and Molecular Biology 3 13%
Medicine and Dentistry 2 8%
Nursing and Health Professions 1 4%
Immunology and Microbiology 1 4%
Other 4 17%
Unknown 9 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2022.
All research outputs
#4,316,584
of 25,392,582 outputs
Outputs from Therapeutics and Clinical Risk Management
#208
of 1,323 outputs
Outputs of similar age
#91,144
of 433,636 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 18 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,636 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.